Tilray Brands, Inc. (TLRY)
NASDAQ: TLRY · Real-Time Price · USD
4.840
+0.170 (3.64%)
At close: Aug 21, 2026, 4:00 PM EDT
4.845
+0.005 (0.10%)
After-hours: Aug 21, 2026, 7:57 PM EDT
Tilray Brands Revenue
In the fiscal year ending May 31, 2026, Tilray Brands had annual revenue of $915.45M with 11.46% growth. Tilray Brands had revenue of $281.71M in the quarter ending May 31, 2026, with 25.47% growth.
Revenue (ttm)
$915.45M
Revenue Growth
+11.46%
P/S Ratio
0.72
Revenue / Employee
$254,646
Employees
3,595
Market Cap
656.37M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2026 | 915.45M | 94.15M | 11.46% |
| May 31, 2025 | 821.31M | 32.37M | 4.10% |
| May 31, 2024 | 788.94M | 161.82M | 25.80% |
| May 31, 2023 | 627.12M | -1.25M | -0.20% |
| May 31, 2022 | 628.37M | 115.29M | 22.47% |
| May 31, 2021 | 513.09M | 302.60M | 143.77% |
| Dec 31, 2020 | 210.48M | -194.84M | -48.07% |
| May 31, 2020 | 405.33M | 238.35M | 142.74% |
| Dec 31, 2019 | 166.98M | 123.85M | 287.15% |
| Dec 31, 2018 | 43.13M | 22.59M | 110.00% |
| Dec 31, 2017 | 20.54M | 7.89M | 62.43% |
| Dec 31, 2016 | 12.64M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Evotec SE | 819.47M |
| Collegium Pharmaceutical | 808.21M |
| Pacira BioSciences | 746.16M |
| Amphastar Pharmaceuticals | 730.02M |
| Ironwood Pharmaceuticals | 389.32M |
| Evolus | 316.49M |
| Canopy Growth | 206.77M |
| Kamada | 191.85M |
TLRY News
- 2 days ago - Tilray Strengthens Global Medical Cannabis Leadership with Major Production Increase to Meet International Demand - GlobeNewsWire
- 4 days ago - Top Canadian Cannabis Stocks to Watch in August 2026 - MarijuanaStocks
- 4 days ago - BrewDog Unwraps Its 2026 Advent Calendar - GlobeNewsWire
- 4 days ago - Tilray Medical Welcomes Progress in Germany's Medical Cannabis Framework and Supports Continued Policy Development - GlobeNewsWire
- 5 days ago - Montauk Brewing Company Expands Its Coastal Footprint with New North Shore Brewpub - GlobeNewsWire
- 5 days ago - Tilray Medical Accelerates the Commercial Expansion of Tilray Medical-Branded Cannabis Medicines in the UK with First Direct-to-Patient Launch Through Lyphe Clinic and Lyphe Dispensary - GlobeNewsWire
- 7 days ago - Marijuana reform is emerging as a midterm elections issue on both sides of the aisle - CNBC
- 9 days ago - Montauk Brewing Company Announces New Collaboration with Morning Brew Inc. - GlobeNewsWire